GLG Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-47,570
Closed -$1.72M 516
2016
Q4
$1.72M Sell
47,570
-3,914
-8% -$156K 0.07% 235
2016
Q3
$2.37M Buy
51,484
+17,179
+50% +$896K 0.07% 273
2016
Q2
$1.72M Sell
34,305
-825
-2% -$43.9K 0.05% 298
2016
Q1
$1.88M Sell
35,130
-305,125
-90% -$17.9M 0.05% 274
2015
Q4
$22.3M Sell
340,255
-132,716
-28% -$8.2M 0.71% 37
2015
Q3
$26.7M Sell
472,971
-110,620
-19% -$7.17M 0.71% 34
2015
Q2
$34.5M Buy
583,591
+463,134
+384% +$28.6M 0.89% 23
2015
Q1
$7.5M Sell
120,457
-61,672
-34% -$3.59M 0.25% 123
2014
Q4
$10.5M Sell
182,129
-557,106
-75% -$31M 0.31% 94
2014
Q3
$39.7M Sell
739,235
-227,713
-24% -$12.1M 0.91% 19
2014
Q2
$50.7M Buy
966,948
+727,830
+304% +$37.2M 1.21% 14
2014
Q1
$12.6M Buy
239,118
+164,118
+219% +$7.59M 0.25% 114
2013
Q4
$3.01M Hold
75,000
0.21% 104
2013
Q3
$2.83M Sell
75,000
-207,766
-73% -$8.1M 0.26% 101
2013
Q2
$11.1M Buy
+282,766
New +$11M 0.42% 76

Other funds holding TEVA